Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function

The Journal of Clinical Investigation
C A VerdonkF J Service


Gastric inhibitory polypeptide (GIP) is considered to be the principal mediator of the enteroinsular axis. A glucose-insulin clamp technique was used to study the effects of differing blood glucose levels on the insulinotropic and glucagonotropic actions of fat-stimulated GIP in seven healthy subjects, as well as the effect of physiologic hyperinsulinemia on GIP secretion. Blood glucose levels were clamped for 4 h at 43+/-2 mg/dl (hypoglycemic clamp), 88+/-1 mg/dl (euglycemic clamp), and 141+/-2 mg/dl (hyperglycemic clamp) in the presence of a constant insulin infusion (100 m U/kg per h). Under hypoglycemic clamp conditions there was no increase in C-peptide nor glucagon after Lipomul ingestion, despite an increase of GIP of 51.7+/-8.7 ng/ml per 120 min. Under euglycemic clamp conditions, small and inconsistent increases in C-peptide and glucagon were observed after fat ingestion and a concomitant increase of GIP of 35.2+/-9.4 ng/ml per 120 min. Under hyperglycemic clamp conditions after fat ingestion and a GIP increase of 24.0+/-5.7 ng/ml per 120 min, C-peptide increased from 6.4+/-5 ng/ml to 11.0+/-1.1 ng/ml (P < 0.01) but glucagon did not change. These findings confirm that in healthy man GIP exerts its insulinotropic proper...Continue Reading


Feb 1, 1979·Diabetologia·W Creutzfeldt
Apr 1, 1979·Diabetologia·L M MorganV Marks
Apr 1, 1975·Canadian Journal of Physiology and Pharmacology·R A PedersonJ C Brown
Oct 1, 1973·The Journal of Clinical Investigation·I BöttgerR H Unger
Nov 1, 1973·The Journal of Clinical Endocrinology and Metabolism·J DupreJ C Brown
Jul 16, 1970·The New England Journal of Medicine·W A MüllerR H Unger
Oct 1, 1965·The Journal of Clinical Endocrinology and Metabolism·V HerbertS J Bleicher


Oct 1, 1984·Diabetologia·W Creutzfeldt
May 1, 1985·The Journal of Clinical Investigation·G BolliJ E Gerich
Jun 1, 1985·Archives internationales de physiologie et de biochimie·B Beck, C Villaume
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Jan 1, 1986·Diabetes/metabolism Reviews·W K WardD Porte
Jan 1, 1987·Diabetes/metabolism Reviews·R Ebert, W Creutzfeldt
Aug 1, 1985·Diabetologia·W Creutzfeldt, R Ebert
Jun 1, 1989·Scandinavian Journal of Clinical and Laboratory Investigation·P H Groop
Apr 1, 1985·Scandinavian Journal of Clinical and Laboratory Investigation·P H GroopL C Groop
Feb 1, 1995·Pharmazie in unserer Zeit·M A Wahl
Feb 11, 2021·Diabetologia·Therese W FabriciusHypo-RESOLVE consortium

Related Concepts

Blood Glucose
Gastric Inhibitory Polypeptide
Enteric Hormones
Islets of Langerhans

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.